![Margaret Gill](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Margaret Gill
Directeur/Membre du Conseil chez Global Alliance for Livestock Veterinary Medicines
Provenance du réseau au premier degré de Margaret Gill
Entité | Type d'entité | Industrie | |
---|---|---|---|
Global Alliance for Livestock Veterinary Medicines
![]() Global Alliance for Livestock Veterinary Medicines Miscellaneous Commercial ServicesCommercial Services The Global Alliance for Livestock Veterinary Medicines provides social services. The CEO of the British company is Peter Jeffries.
11
| Non-Profit Organization | Miscellaneous Commercial Services | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Margaret Gill via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Elanco Tiergesundheit AG
![]() Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Intervet International BV
![]() Intervet International BV Pharmaceuticals: MajorHealth Technology Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | Pharmaceuticals: Major | Sales & Marketing | |
Novavax AB
![]() Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
The University of Nottingham | College/University | Doctorate Degree | |
The Moredun Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Jenner Vaccine Foundation | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 4 |
Etats-Unis | 2 |
Suisse | 2 |
Pays-Bas | 2 |
Suède | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Miscellaneous | 2 |
Opérationnelle
Director/Board Member | 10 |
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sales & Marketing | 1 |
Doctorate Degree | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Margaret Gill
- Connexions Sociétés